Both in Pharmaceuticals
Syndax Pharmaceuticals vs Rigel Pharmaceuticals Inc. (New)
Over the past year SNDX returned −31.9% and RIGL returned +80.7%; their daily moves had a correlation of 0.23.
SNDX −31.9% RIGL +80.7%Growth of $1, one year, split-adjusted
| Metric | SNDX | RIGL |
|---|---|---|
| Price | $10.45 | $51.29 |
| Market cap | $933.2M | $958.1M |
| Today | −26.87% | +4.97% |
| 1 month | −39.8% | +11.2% |
| 6 months | −49.4% | +92.3% |
| Year to date | −50.3% | +19.8% |
| 1 year | −24.1% | +67.3% |
| Revenue growth (YoY) | +81.6% | −22.6% |
| Gross margin | 83.2% | 89.2% |
| Net margin | −59.3% | 22.0% |
| P/E (TTM) | — | 3.0× |
| Price / sales | 3.2× | 3.5× |
| Net cash | $182.3M | $56.1M |
| Dividend yield | — | — |
| Volatility (60d) | 84.0% | 37.8% |
| Short % of float | 21.4% | 16.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).